These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
168 related items for PubMed ID: 31156713
21. Atypical hemolytic uremic syndrome: update on the complement system and what is new. Hirt-Minkowski P, Dickenmann M, Schifferli JA. Nephron Clin Pract; 2010; 114(4):c219-35. PubMed ID: 20090363 [Abstract] [Full Text] [Related]
22. Hypertension-associated thrombotic microangiopathy in an adult patient with complement factor H autoantibodies and a rare heterozygous variant in the CFH gene. Roldão M, Valério Alves R, Escoli R, Gonçalves H, Lopes K. Clin Nephrol; 2021 Aug; 96(2):124-128. PubMed ID: 34032207 [Abstract] [Full Text] [Related]
23. Novel Heterozygous Missense Variants in Diacylglycerol Kinase Epsilon and Complement Factor I: Potential Pathogenic Association With Atypical Hemolytic Uremic Syndrome. Abughanimeh OK, Baljevic M, Nester A. Cureus; 2024 Jan; 16(1):e52633. PubMed ID: 38374836 [Abstract] [Full Text] [Related]
24. Genetic Analysis of 400 Patients Refines Understanding and Implicates a New Gene in Atypical Hemolytic Uremic Syndrome. Bu F, Zhang Y, Wang K, Borsa NG, Jones MB, Taylor AO, Takanami E, Meyer NC, Frees K, Thomas CP, Nester C, Smith RJH. J Am Soc Nephrol; 2018 Dec; 29(12):2809-2819. PubMed ID: 30377230 [Abstract] [Full Text] [Related]
25. Copy number variation analysis using next-generation sequencing identifies the CFHR3/CFHR1 deletion in atypical hemolytic uremic syndrome: a case report. Park J, Yhim HY, Kang KP, Bae TW, Cho YG. Hematology; 2022 Dec; 27(1):603-608. PubMed ID: 35617302 [Abstract] [Full Text] [Related]
26. Genetic analysis and functional characterization of novel mutations in a series of patients with atypical hemolytic uremic syndrome. Szarvas N, Szilágyi Á, Csuka D, Takács B, Rusai K, Müller T, Arbeiter K, Réti M, Haris Á, Wagner L, Török S, Kelen K, Szabó AJ, Reusz GS, Morgan BP, Prohászka Z. Mol Immunol; 2016 Mar; 71():10-22. PubMed ID: 26826462 [Abstract] [Full Text] [Related]
27. The interactive Factor H-atypical hemolytic uremic syndrome mutation database and website: update and integration of membrane cofactor protein and Factor I mutations with structural models. Saunders RE, Abarrategui-Garrido C, Frémeaux-Bacchi V, Goicoechea de Jorge E, Goodship TH, López Trascasa M, Noris M, Ponce Castro IM, Remuzzi G, Rodríguez de Córdoba S, Sánchez-Corral P, Skerka C, Zipfel PF, Perkins SJ. Hum Mutat; 2007 Mar; 28(3):222-34. PubMed ID: 17089378 [Abstract] [Full Text] [Related]
28. Atypical Hemolytic Uremic Syndrome Presenting as Pre-eclampsia in a 24-year-old Woman with Chronic Kidney Disease: Pathogenesis and Genetics. Kalambay J, Zaman R, Zaman M. Cureus; 2018 Sep 25; 10(9):e3358. PubMed ID: 30510868 [Abstract] [Full Text] [Related]
29. Distal Angiopathy and Atypical Hemolytic Uremic Syndrome: Clinical and Functional Properties of an Anti-Factor H IgAλ Antibody. Rigothier C, Delmas Y, Roumenina LT, Contin-Bordes C, Lepreux S, Bridoux F, Goujon JM, Bachelet T, Touchard G, Frémeaux-Bacchi V, Combe C. Am J Kidney Dis; 2015 Aug 25; 66(2):331-6. PubMed ID: 26015278 [Abstract] [Full Text] [Related]
30. Familial Atypical Hemolytic Uremic Syndrome with Positive p.S1191L (c.3572C>T) Mutation on the CFH Gene: A Single-center Experience. Ersoy Dursun F, Yesil G, Sasak G, Dursin H. Balkan J Med Genet; 2021 Jun 25; 24(1):81-88. PubMed ID: 34447663 [Abstract] [Full Text] [Related]
31. [Atypical HUS caused by complement-related abnormalities]. Yoshida Y, Matsumoto M. Rinsho Ketsueki; 2015 Feb 25; 56(2):185-93. PubMed ID: 25765799 [Abstract] [Full Text] [Related]
32. Efficacy and safety of eculizumab in adult patients with atypical hemolytic uremic syndrome: A single center experience from Turkey. Gediz F, Payzin BK, Ecemis S, Güler N, Yilmaz AF, Topcugil F, Berdeli A. Transfus Apher Sci; 2016 Dec 25; 55(3):357-362. PubMed ID: 27742267 [Abstract] [Full Text] [Related]
33. Atypical hemolytic uremic syndrome in first trimester pregnancy successfully treated with eculizumab. Andries G, Karass M, Yandrapalli S, Linder K, Liu D, Nelson J, Pawar R, Chugh S. Exp Hematol Oncol; 2017 Dec 25; 6():4. PubMed ID: 28101432 [Abstract] [Full Text] [Related]
34. [Clinical characteristics and genetic profile of complement system in renal thrombotic microangiopathy in patients with severe forms of arterial hypertension]. Akaeva MI, Kozlovskaya NL, Bobrova LA, Vorobyeva OA, Stoliarevich ES, Shatalov PA, Smirnova TV, Anan'eva AO. Ter Arkh; 2024 Jul 07; 96(6):571-579. PubMed ID: 39106497 [Abstract] [Full Text] [Related]
35. Overactivation of Complement Alternative Pathway in Postpartum Atypical Hemolytic Uremic Syndrome Patients with Renal Involvement. Song D, Yu XJ, Wang FM, Xu BN, He YD, Chen Q, Wang SX, Yu F, Song WC, Zhao MH. Am J Reprod Immunol; 2015 Oct 07; 74(4):345-56. PubMed ID: 26011580 [Abstract] [Full Text] [Related]
36. Complement gene variant effect on relapse of complement-mediated thrombotic microangiopathy after eculizumab cessation. Acosta-Medina AA, Moyer AM, Go RS, Willrich MAV, Fervenza FC, Leung N, Bourlon C, Winters JL, Spears GM, Bryant SC, Sridharan M. Blood Adv; 2023 Feb 14; 7(3):340-350. PubMed ID: 35533258 [Abstract] [Full Text] [Related]
37. Atypical hemolytic-uremic syndrome due to complement factor I mutation. Almalki AH, Sadagah LF, Qureshi M, Maghrabi H, Algain A, Alsaeed A. World J Nephrol; 2017 Nov 06; 6(6):243-250. PubMed ID: 29226095 [Abstract] [Full Text] [Related]
38. Treatment of Atypical Hemolytic-Uremic Syndrome in the Era of Eculizumab. Ebrahem R, Kadhem S, Truong Q. Cureus; 2017 Mar 23; 9(3):e1111. PubMed ID: 28439485 [Abstract] [Full Text] [Related]
39. Atypical Hemolytic Uremic Syndrome following Acute Type A Aortic Dissection. Ikushima E, Hisahara M, Nishijima T, Uchiyama H, Onzuka T, Ochiai Y, Muta T, Tokunaga S. Case Rep Hematol; 2020 Mar 23; 2020():2467953. PubMed ID: 32190391 [Abstract] [Full Text] [Related]
40. Implications of the initial mutations in membrane cofactor protein (MCP; CD46) leading to atypical hemolytic uremic syndrome. Richards A, Kathryn Liszewski M, Kavanagh D, Fang CJ, Moulton E, Fremeaux-Bacchi V, Remuzzi G, Noris M, Goodship TH, Atkinson JP. Mol Immunol; 2007 Jan 23; 44(1-3):111-22. PubMed ID: 16882452 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]